Logo do repositório
 
Publicação

The pleural mesothelioma cases and mortality in portugal in 2014–2020

dc.contributor.authorSantos, Cátia
dc.contributor.authorSacadura-Leite, Ema
dc.contributor.authorFerreira, Joana
dc.contributor.authorDixe, Maria dos Anjos
dc.contributor.authorAstoul, Philippe
dc.contributor.authorSousa-Uva, António
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.institutionComprehensive Health Research Centre (CHRC) - Pólo ENSP
dc.contributor.institutionCentro de Investigação em Saúde Pública (CISP/PHRC)
dc.contributor.pblMDPI - Multidisciplinary Digital Publishing Institute
dc.date.accessioned2024-06-28T22:24:39Z
dc.date.available2024-06-28T22:24:39Z
dc.date.issued2024-06
dc.descriptionPublisher Copyright: © 2024 by the authors.
dc.description.abstractBackground: The incidence and mortality of pleural mesothelioma (PM) reflect the production and consumption of asbestos over time. However, despite the current global concern, these data remain to be known. Objective: Our aim was to carry out a descriptive analysis of PM cases and mortality from some Portuguese databases between 2014 and 2020. Methods: A retrospective observational study was carried out between 2014 and 2020. Data on the number of PM cases were provided by the Portuguese Cancer Registry, and data on mortality were from the Portuguese Death Certificate Information System. Results: Between 2014 and 2020, 315 cases of PM were reported, with 222 (70.5%) men. The average age of patients was 72.1, with the highest number of cases in patients aged >70 years (n = 198; 62.9%). The highest number of cases was reported in 2018 (n = 62; 19.7%). Regarding mortality, 169 deaths were reported, with 126 (74.6%) men and mostly in individuals aged >70 years (n = 109; 64.5%). It is estimated that around 520 years of potential life were lost. The highest number of deaths occurred in 2015 (n = 33; 19.5%). Conclusion: It is mandatory to reinforce the need for surveillance programs that allow us to gather real and reliable data and eliminate asbestos-related diseases.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent507102
dc.identifier.doi10.3390/healthcare12111103
dc.identifier.issn2227-9032
dc.identifier.otherPURE: 94049874
dc.identifier.otherPURE UUID: ab05a18b-b34a-4b41-9c40-f8c310fcf811
dc.identifier.otherScopus: 85195934523
dc.identifier.otherWOS: 001247000100001
dc.identifier.otherPubMed: 38891178
dc.identifier.otherPubMedCentral: PMC11171679
dc.identifier.urihttp://hdl.handle.net/10362/169184
dc.identifier.urlhttps://www.scopus.com/pages/publications/85195934523
dc.language.isoeng
dc.peerreviewedyes
dc.subjectasbestos
dc.subjectexposure
dc.subjectincidence
dc.subjectmalignant mesothelioma
dc.subjectmortality
dc.subjectpleural mesothelioma
dc.subjectyears of life loss
dc.subjectLeadership and Management
dc.subjectHealth Policy
dc.subjectHealth Informatics
dc.subjectHealth Information Management
dc.subjectSDG 3 - Good Health and Well-being
dc.titleThe pleural mesothelioma cases and mortality in portugal in 2014–2020en
dc.title.subtitlea descriptive studyen
dc.typejournal article
degois.publication.issue11
degois.publication.titleHealthcare (Switzerland)
degois.publication.volume12
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Santos_2024_Healthcare_12_1103.pdf
Tamanho:
495.22 KB
Formato:
Adobe Portable Document Format